Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
HCWB
#4490
HCW Biologics Inc. Common Stock
0.398
9
USD
+6.92%
Sektor:
Gesundheitswesen
Basis:
USD
Gewinnwährung:
USD
Tagesspanne
Jahresspanne
Tagesänderung
+6.92%
Monatliche Änderung
-24.82%
6 month change
-35.24%
Jahresänderung
-35.24%
Vorheriger Schlusskurs
0.373
1
Open
0.398
9
Bid
0.398
9
Ask
0.401
9
Low
0.398
9
High
0.398
9
Volumen
8
Märkte
Aktien
Gesundheitswesen
HCWB
Open full chart
Financials
Overview
Finanzbericht
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
945.58 K
1.12 M
1.44 M
2.15 M
2.7 M
—
Valuation ratios
Enterprise value
—
—
—
12.88 M
15.71 M
—
Price to earnings ratio
—
—
—
-0.19
-0.19
—
Price to sales ratio
—
—
—
4.6
8.86
—
Price to cash flow ratio
—
—
—
-0.5
-0.59
—
Price to book ratio
—
—
—
-0.22
-0.45
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.15
-0.11
-0.08
-0.07
-0.18
-0.44
Return on equity %
0.39
0.5
0.26
37.09
2.16
40.01
Return on invested capital %
-27.68
-23.78
-15.19
—
-25.73
—
Gross margin %
20
20
20
20
20
80
Operating margin %
-865.39
-801.78
-38.81 K
-52.89 K
-21.1 K
-113.6 K
EBITDA margin %
-835.27
-628.91
-30.54 K
—
—
—
Net margin %
-915.12
-854.42
-43.37 K
-29.43 K
-29.18 K
-102.84 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
0.07
0.19
0.07
0.11
0.06
0.43
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.02
0.01
0
0
0
0.01
Solvency ratios
Debt to assets ratio
0.48
0.45
0.53
0.23
0.27
1.49
Debt to equity ratio
-1.28
-2.02
-1.63
-130.62
-3.23
-137.5
Long term debt to total assets ratio
0.24
0.24
0.29
0.01
0
0.55
Long term debt to total equity ratio
-0.65
-1.09
-0.9
-7.06
0
-9.05
Per share metrics
Operating cash flow per share
-3.09
-2.92
-0.08
-1.84
-1.43
-6.28
EBIT per share
-3.9
-3.26
-0.04
-1.95
-1.46
-6.71
EBITDA per share
-3.77
-2.56
-0.03
—
—
—
Total debt per share
13.54
14.12
0.31
3.81
3.01
21.26
Cash per share
1.06
4.82
0.02
1.37
0.49
6.7
Net current asset value per share
2.21
5.88
0.04
1.63
0.7
8.25
Tangible book value per share
-10.54
-6.98
-0.19
-0.03
-0.93
-8.13
Working capital per share
-29.58
-24.67
-0.57
-13.45
-11.18
-49.88
Book value per share
-10.54
-6.98
-0.19
-0.03
-0.93
-8.13
Nachrichten
HCW Biologics receives $7M upfront fee from China licensee
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.83%
Forschungserfolg bei HCW Biologics: Wirkstoff verbessert Herstellung von CAR-T-Zellen
HCW Biologics’ compound shows promise in CAR-T cell production
HCW Biologics: 7-Millionen-Dollar-Lizenzdeal mit Partner in China
HCW Biologics enters $7 million licensing deal with China-based Trimmune
HCW Biologics ergreift Maßnahmen zur Wiedererlangung der Nasdaq-Konformität
HCW Biologics reports steps to regain Nasdaq compliance following equity transactions
HCW Biologics sichert sich 4 Millionen Dollar durch Optionsschein-Vereinbarung
HCW Biologics secures $4 million through warrant exercise agreement
HCW Biologics schließt geänderte Lizenzvereinbarung mit Beijing Trimmune Biotech ab
HCW Biologics enters amended licensing agreement with Beijing Trimmune Biotech